Latest News
See all →
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
Garching / Munich, Germany and Sydney, Australia, May 19, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech…
Read more
ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
Garching / Munich, Germany and VANCOUVER, British Columbia, April 24, 2025 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical…
Read more
Barbara Weber, M.D., Elected to ITM Supervisory Board
Garching / Munich, Germany, April 09, 2025 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced…
Read more
